Participated · Seed · Aug 2026

Zerolook uses machine-learning models trained on historical fares, schedules and availability to predict flight options and prices, returning each prediction with a confidence score. The product sacrifices some real-time accuracy in order to answer far larger volumes of search queries at lower cost compared with live pricing systems. The founders—Simone Lini (ex-Google Flights/Waynaut) and George Hadjiyiannis (PhD, MIT; ex-Kayak/Google/Nvidia/eBay)—intend to validate the approach through pilot programs with online travel partners. Zerolook plans to launch its first API and expand its machine-learning team in Zurich using proceeds from the pre-seed round. The company cites industry trends—searches per ticket sold rising from hundreds to tens of thousands and projected to reach millions by 2030—that drive demand for lower-cost search infrastructure. It operates in a market for flight data APIs valued at $1.72 billion in 2025 and projected to grow to $4.67 billion by 2033, and the pilots are intended to determine whether predictive pricing is sufficiently accurate for airlines and OTAs.

Participated · Series B · Feb 2026

Artificial Labs builds a proprietary platform that digitises complex insurance workflows for brokers, carriers, and MGAs, allowing them to optimise capacity deployment and trade risks more efficiently. The company combines deep insurance domain expertise with modern engineering to capture institutional knowledge and integrate seamlessly with existing systems. Clients include some of the world’s largest brokers and carriers in the London Market, reflecting strong adoption in specialty and commercial insurance. With the fresh capital, Artificial Labs plans to double its headcount over the next 12 months and further invest in product innovation. The firm will also expand its global footprint, consolidating its London leadership while entering the U.S. market in 2026. Investors praise the platform’s ability to solve structural efficiency constraints that have persisted in specialty risk placement for decades. Although exact revenue or user metrics were not disclosed, the company positions itself as a key technology partner capable of supporting the largest brokers and carriers as they modernise operations.

Participated · Series A · May 2023

Laced is a UK-based resale marketplace that facilitates authenticated sales of premium sneakers between anonymous buyers and sellers. Sellers list new, boxed trainers at a set price; listings are queued and prioritized by lowest price to encourage reasonable pricing. After a sale, sellers ship items to Laced's in-house authenticators, who verify items before forwarding them to buyers; Laced takes a 15% cut on the list price. Founded in London in 2018, the company focuses exclusively on the UK market and emphasizes anonymity for both buyers and sellers. Laced has built a proprietary tech stack and an authentication system that uses pattern identification, a large database of silhouette-specific variables, and an internal training syllabus. The company has raised $12M in a Series A (on top of a $1M pre-seed) and plans to invest in technology, product and data science to scale its platform in a crowded resale market.

Participated · Seed · Mar 2023

Cordless is a London-based provider of cloud-based call centre software built with conversation intelligence, led by CEO Luba Chudnovets and CTO Irina Bednova. Its platform enables customer support teams to talk to customers over the phone and automatically captures transcriptions, sentiment analysis, and auto-tagging of conversations. Deep integrations with popular CRMs allow managers to identify areas for improvement, training opportunities, and trends in customer queries, and to share insights with broader teams. The company currently serves customers including Curve, Plend, Second Nature, and Fronted. Cordless raised $2.3M in Seed funding and intends to use the proceeds for customer acquisition and product development. The round was led by Fly Ventures with participation from Passion Capital, TrueSighy, and Renaud Visage.

Led · Seed · Jan 2023

Veratrak is modernizing life‑sciences supply chains by linking the backend systems used by pharmaceutical manufacturers, logistics and contract manufacturing and packaging teams. Its product connects disparate systems to prevent costly mistakes—such as misprinted labels or incorrect paperwork—and provides role-specific visibility to drive better decisions at every stage. CEO and founder Jason Lacombe created the company after many years observing how these supply chains fail in practice. Veratrak works with over 90 companies across six continents, including very large global pharmaceutical firms and their supply‑chain partners. Financially, the company announced a £5.3M seed round led by Crane Venture Partners. The team positions the product to drive efficiency and resilience in drug manufacturing and delivery, with the goal of ensuring patients receive medicines when they need them. Veratrak offers a document collaboration and workflow management platform built for the pharmaceutical industry to onboard internal and external partners to verify, authenticate, review and sign-off critical documentation across production, packaging, shipping and dispensing. The SaaS enables chronological execution of steps required to release a product to market and lets users communicate with supply-chain partners at different organisations. The platform uses blockchain technology to create an "iron-clad audit trail" of all document events and is built to be GAMP 5 compliant to meet high security and quality standards. Veratrak says this reduces the regulatory burden on customers, increases visibility for supply-chain partners and improves the ability to react to events. The company charges a monthly per-head license fee, with volume-based pricing and free guest licenses for external partners to drive network effects. Veratrak was launched in August 2018 and recently secured seed funding of £1 million.